64
Participants
Start Date
November 29, 2023
Primary Completion Date
November 11, 2025
Study Completion Date
February 1, 2028
Dupilumab
Subcutaneous injection (SC) as per protocol
Placebo
SC injection as per protocol
Investigational Site Number : 7560002, Zurich
Investigational Site Number : 7560001, Wetzikon
Penn Medicine: University of Pennsylvania Health System- Site Number : 8400010, Philadelphia
University of North Carolina at Chapel Hill- Site Number : 8400007, Chapel Hill
Borland Groover Clinic- Site Number : 8400016, Jacksonville
Cleveland Clinic - Cleveland- Site Number : 8400009, Cleveland
University of Iowa- Site Number : 8400006, Iowa City
Mayo Clinic Hospital Rochester- Site Number : 8400008, Rochester
GI Alliance - Glenview- Site Number : 8400012, Glenview
Illinois Gastroenterology Group- Site Number : 8400004, Gurnee
Northwestern University- Site Number : 8400003, Chicago
GI Alliance - Mansfield- Site Number : 8400017, Mansfield
Private Practice - Dr. Martin Yudovich- Site Number : 8400015, Houston
Treasure Valley Medical Research- Site Number : 8400018, Boise
United Gastroenterologists - Murrieta- Site Number : 8400001, Murrieta
University of California San Francisco - Parnassus Heights- Site Number : 8400020, San Francisco
Investigational Site Number : 3760006, Haifa
Investigational Site Number : 3760002, Haifa
Investigational Site Number : 3760003, Tel Aviv
Investigational Site Number : 3760005, Jerusalem
Investigational Site Number : 3760004, Jerusalem
University of Massachusetts Chan Medical School- Site Number : 8400019, Worcester
Itaigara Memorial - Hospital Dia- Site Number : 0760005, Salvador
Hospital São Lucas da PUCRS - Porto Alegre - Avenida Ipiranga- Site Number : 0760006, Porto Alegre
Clínica Loema - Unidade I- Site Number : 0760007, Campinas
Clinica de Alergia Martti Antila- Site Number : 0760001, Sorocaba
Hospital Alemao Oswaldo Cruz - São Paulo- Site Number : 0760003, São Paulo
Investigational Site Number : 1240006, Vancouver
Investigational Site Number : 1240004, Vancouver
Investigational Site Number : 1240002, Montreal
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY